Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on April 26th, 2023%
A study of insurance claims records matching the design of randomized clinical trials shows claims data can in some cases resemble clinical trial results to make causal inferences. . . . → Read More: Real World Evidence Shown to Emulate Some Clinical Trials
By Alan, on April 10th, 2023%
A biotechnology industry group calls Friday’s ruling in a Federal district court to suspend approval of the drug mifepristone “an assault on science.” . . . → Read More: Biotech Group Blasts Reproductive Drug Ruling
By Alan, on April 5th, 2023%
A developer of treatments for eye diseases says it received clearance from FDA to begin a clinical trial of a sustained-release implant therapy for glaucoma. . . . → Read More: Trial Okayed for Glaucoma Treatment Implant
By Alan, on March 10th, 2023%
A team from an academic medical center and research institute are evaluating a personalized dialysis model for people with kidney disease, but with still some kidney functions. . . . → Read More: PCORI Funds Personal Dialysis Model Assessment
By Alan, on March 3rd, 2023%
A panel of data scientists at a professional meeting says artificial intelligence needs more rigorous oversight, but many questions remain on who and how to do the regulating. . . . → Read More: Panel: A.I. Regulation Needed, But Long Way Off
By Alan, on December 28th, 2022%
The opioid overdose drug naloxone in nasal spray form is receiving priority review from the Food and Drug Administration as an over-the-counter drug. . . . → Read More: Over-the-Counter Naloxone Receiving Faster FDA Review
By Alan, on December 6th, 2022%
The Food and Drug Administration authorized for marketing an algorithm-driven medical device for diagnosing a common, but difficult to detect, type of heart failure. . . . → Read More: FDA Clears AI Heart Failure Detection System
By Alan, on November 23rd, 2022%
A developer of remote health tracking technology says the Food and Drug Administration cleared its continuous patient monitoring system for clinical use. . . . → Read More: FDA Clears Digital Health Monitoring System
By Alan, on November 15th, 2022%
A start-up enterprise seeks to make drugs for treating rare diseases more readily available to physicians and patients in Europe. . . . → Read More: Company to Boost Orphan Drugs in Europe
By Alan, on November 2nd, 2022%
A vaccine designed from engineered live viruses and taken as nose drops to prevent respiratory syncytial virus received a Food and Drug Administration fast-track designation. . . . → Read More: RSV Nose Drops Vaccine Gets FDA Fast Track Tag
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|